Which institutions are considered best for managing high‑risk prostate cancer and performing prostatectomy?

High-Volume Surgical Centers Are Best for High-Risk Prostate Cancer and Prostatectomy

For high-risk prostate cancer requiring radical prostatectomy, seek treatment at high-volume surgical centers with experienced surgeons, as these institutions consistently demonstrate superior oncologic and functional outcomes. 1

Why High-Volume Centers Matter

The evidence clearly demonstrates that high-volume surgeons in high-volume centers generally provide superior outcomes for radical prostatectomy 1. This volume-outcome relationship is particularly critical for high-risk disease, where surgical complexity increases due to:

• Higher rates of extracapsular extension requiring meticulous dissection
• Need for extended pelvic lymph node dissection (PLND)
• Greater likelihood of requiring nerve-sparing modifications
• Increased risk of positive surgical margins requiring expert technique

Specific Institutional Characteristics to Seek

Surgical Expertise

Look for centers that offer:

• Robotic or minimally invasive approaches performed by experienced surgeons, which demonstrate shorter hospital stays, less blood loss, and fewer surgical complications compared to open approaches 1
• Surgeons performing high volumes of radical prostatectomies annually (typically >50-100 cases/year)
• Multidisciplinary tumor boards with urologic oncologists, radiation oncologists, and medical oncologists

Multimodal Treatment Capabilities

High-risk prostate cancer often requires multimodal therapy, so ideal institutions should provide:

• Immediate access to adjuvant radiation therapy if pathology reveals adverse features (positive margins, seminal vesicle invasion, extracapsular extension) 1
• Clinical trials evaluating novel systemic therapies combined with surgery 2
• Advanced imaging capabilities (multiparametric MRI, PSMA PET) for accurate staging 2

Notable Centers with Published Outcomes

The Mayo Clinic has specifically published their institutional experience with surgical management of high-risk prostate cancer, demonstrating long-term expertise in this challenging population 3. However, this doesn't mean other high-volume academic centers lack equivalent expertise.

What Defines "High-Volume" in Practice

While specific institutional names vary by region, prioritize centers that:

• Are tertiary referral centers with published outcomes in high-risk disease 4
• Perform extended PLND routinely (removing ≥10-15 lymph nodes) 1
• Have dedicated genitourinary pathologists for accurate Gleason grading
• Offer same-institution access to salvage therapies if needed

Common Pitfalls to Avoid

Do not assume all academic centers are equivalent. Even among teaching hospitals, surgical volume and outcomes vary significantly. Specifically ask about:

• Annual institutional radical prostatectomy volume
• Individual surgeon's experience with high-risk cases
• Rates of positive surgical margins in high-risk patients
• Availability of nerve-sparing techniques even in high-risk disease 1

Avoid centers that cannot provide multimodal care. High-risk disease frequently requires adjuvant treatment—37% of very high-risk patients have positive lymph nodes and 37% have positive margins 4. If radiation oncology or medical oncology expertise isn't immediately available, outcomes may suffer.

Functional Outcomes Also Depend on Volume

High-volume centers demonstrate better functional outcomes beyond cancer control:

• 12-month urinary continence rates are significantly better with robotic approaches at experienced centers 1
• Potency recovery is superior when nerve-sparing is performed by high-volume surgeons 1
• Rates of anastomotic strictures and long-term incontinence are lower 1

The toxicity rates from the SPCG-4 trial (80% erectile dysfunction, 49% urinary leakage) may not be generalizable to high-volume surgical centers with modern techniques 5.

Geographic Considerations

If you cannot access a high-volume center locally, travel to a tertiary center for the surgery itself is worthwhile, even if follow-up care occurs closer to home. The surgical quality at the time of prostatectomy cannot be corrected later, whereas surveillance and adjuvant therapies can often be coordinated with local providers.